InspireMD, Inc.
NSPR
$0.76
-$0.01-1.88%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.91% | 24.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.91% | 24.81% | |||
| Cost of Revenue | 37.68% | 18.69% | |||
| Gross Profit | -41.78% | 36.57% | |||
| SG&A Expenses | 1.15% | -4.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.07% | -2.19% | |||
| Operating Income | -15.67% | 7.41% | |||
| Income Before Tax | -17.02% | 7.95% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.39% | 7.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.39% | 7.45% | |||
| EBIT | -15.67% | 7.41% | |||
| EBITDA | -15.81% | 7.60% | |||
| EPS Basic | -14.36% | 17.46% | |||
| Normalized Basic EPS | -14.98% | 17.85% | |||
| EPS Diluted | -14.36% | 17.46% | |||
| Normalized Diluted EPS | -14.98% | 17.85% | |||
| Average Basic Shares Outstanding | 1.74% | 12.12% | |||
| Average Diluted Shares Outstanding | 1.74% | 12.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||